ProtoKinetix Inc (PKTX)

[Past and present]

(PKTX)..We got a contract!!!PR News.PRESS RELEASE >> SEPTEMBER 03 - 2008
Protokinetix Contracted to Produce AAGP™ for New Product Launch
ProtoKinetix Inc. (PKTX) is pleased to announce their first commercial contract to manufacture and provide AAGP™ as the key active ingredient in a topical anti-inflammatory cream. This new product is expected to be launched within the next few months by the manufacturer of IB Relief, a leader in sports injury relief. The launch will be greatly enhanced by the use of proven channels of distribution to maximize their share of this multi-billion dollar market.
MEKT, LLC, the parent company that produces IB Relief, is a privately held pharmaceutical firm that specializes in topical cream products for pain management. This market, in the U.S. alone, is a $22 billion business growing at 6.6% yearly. MEKT entered into a License Agreement with ProtoKinetix after an extensive evaluation of the testing that has been completed on AAGP™. The formulation and testing of this new product will commence within the next month.
Ross Senior, President and CEO of ProtoKinetix states, “this will be the first of many commercial applications for the powerful and versatile family of AAGP™ molecules. The list of companies actively conducting trials using AAGP™ is growing.”



.